"Medipol Mega Üniversite Hastanesi, bireylerin yaşam kalitesini artırmak adına önleyici ve tedavi edici sağlık hizmetlerini geliştirmeye yönelik önemli adımlar atmaya devam etmektedir."

During the past decade, Medipol Mega University Hospital conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 1 clinical trials were completed, i.e. on average, 5% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 1 clinical trials were completed. i.e. 6.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medipol Mega University Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 7 trials, followed by "Istanbul Medipol University Hospital" with 6 trials sponsored, "Bezmialem Vakif University" with 1 trials sponsored, "Cidara Therapeutics Inc." with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medipol Mega University Hospital" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator and "Pharmacyclics LLC." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Medipol Mega University Hospital" are "Carcinoma, Non-Small-Cell Lung" (4 trials), "Accidental Falls" (1 trials), "Back Pain" (1 trials), "Breast Cancer" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Medipol Mega University Hospital" in a lesser frequency.

Most popular intervention types in "Medipol Mega University Hospital" are "Drug" (11 trials), "Other" (8 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amivantamab" (3 trials), "Placebo" (3 trials), "Carboplatin" (2 trials), "Lazertinib" (2 trials) and "Pemetrexed" (2 trials). Other intervention names were less common.

The vast majority of trials in "Medipol Mega University Hospital" are 18 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Medipol Mega University Hospital". undefined are not yet recruiting, 7 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Medipol Mega University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Medipol Mega University Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".

Medipol Mega University Hospital has several departments that took part in Clinical trials: "Medipol University MF; Oncology Department" - 11 trials